Mark Laws

781 total citations · 1 hit paper
12 papers, 518 citations indexed

About

Mark Laws is a scholar working on Molecular Biology, Pharmacology and Infectious Diseases. According to data from OpenAlex, Mark Laws has authored 12 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pharmacology and 3 papers in Infectious Diseases. Recurrent topics in Mark Laws's work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Cancer therapeutics and mechanisms (2 papers). Mark Laws is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Cancer therapeutics and mechanisms (2 papers). Mark Laws collaborates with scholars based in United Kingdom, Pakistan and Germany. Mark Laws's co-authors include Khondaker Miraz Rahman, Md. Mahbub Hasan, Shirin Jamshidi, Syed Jawad Ali Shah, Jamshed Iqbal, Zahid Shafiq, Rima D. Alharthy, J. Mark Sutton, Rose E. Jeeves and Melanie Clifford and has published in prestigious journals such as Scientific Reports, FEMS Microbiology Reviews and Molecules.

In The Last Decade

Mark Laws

10 papers receiving 504 citations

Hit Papers

Antibody–Drug Conjugates—A Tutorial Review 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Antibody–Drug Conjugates—A Tutorial Review
    2021 167 citations Mark Laws, Khondaker Miraz Rahman et al. Molecules profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Laws United Kingdom 8 182 137 124 95 77 12 518
Philipp Uhl Germany 17 424 2.3× 62 0.5× 63 0.5× 76 0.8× 85 1.1× 58 876
Asif Shahriar Bangladesh 9 326 1.8× 143 1.0× 34 0.3× 36 0.4× 90 1.2× 20 766
Sabesan Yoganathan United States 15 323 1.8× 89 0.6× 35 0.3× 33 0.3× 50 0.6× 32 693
Fenglin Yin United States 10 577 3.2× 113 0.8× 49 0.4× 57 0.6× 198 2.6× 13 877
Michael Wong United States 13 226 1.2× 53 0.4× 77 0.6× 16 0.2× 82 1.1× 22 549
Ibrahim M. El‐Deeb Australia 17 258 1.4× 90 0.7× 52 0.4× 24 0.3× 91 1.2× 38 712
K. M. Kaderi Kibria Bangladesh 12 365 2.0× 232 1.7× 21 0.2× 55 0.6× 88 1.1× 27 865
Fereidoon Daryaee United States 12 227 1.2× 39 0.3× 38 0.3× 77 0.8× 65 0.8× 18 463
Prabhanshu Tripathi United States 8 235 1.3× 78 0.6× 50 0.4× 54 0.6× 41 0.5× 12 393
Catherine Piveteau France 12 220 1.2× 85 0.6× 37 0.3× 21 0.2× 136 1.8× 25 496

Countries citing papers authored by Mark Laws

Since Specialization
Citations

This map shows the geographic impact of Mark Laws's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Laws with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Laws more than expected).

Fields of papers citing papers by Mark Laws

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Laws. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Laws. The network helps show where Mark Laws may publish in the future.

Co-authorship network of co-authors of Mark Laws

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Laws. A scholar is included among the top collaborators of Mark Laws based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Laws. Mark Laws is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Laws, Mark, et al.. (2025). Current economic and regulatory challenges in developing antibiotics for Gram-negative bacteria. PubMed. 3(1). 50–50. 3 indexed citations
2.
3.
4.
Shah, Syed Jawad Ali, Mark Laws, Khondaker Miraz Rahman, et al.. (2022). Development and exploration of novel substituted thiosemicarbazones as inhibitors of aldose reductase via in vitro analysis and computational study. Scientific Reports. 12(1). 5734–5734. 11 indexed citations
5.
Hasan, Md. Mahbub, et al.. (2021). Factors influencing the choice of monoclonal antibodies for antibody–drug conjugates. Drug Discovery Today. 27(1). 354–361. 17 indexed citations
6.
Laws, Mark, et al.. (2021). Efflux pumps in Mycobacterium tuberculosis and their inhibition to tackle antimicrobial resistance. Trends in Microbiology. 30(1). 57–68. 50 indexed citations
7.
Laws, Mark, et al.. (2021). Antibody–Drug Conjugates—A Tutorial Review. Molecules. 26(10). 2943–2943. 167 indexed citations breakdown →
8.
Laws, Mark, Charlotte K. Hind, Shirin Jamshidi, et al.. (2020). N1-Benzofused Modification of Fluoroquinolones Reduces Activity Against Gram-Negative Bacteria. ACS Omega. 5(21). 11923–11934. 5 indexed citations
9.
Laws, Mark, et al.. (2020). Current Trends and Future Approaches in Small-Molecule Therapeutics for COVID-19. Current Medicinal Chemistry. 28(19). 3803–3824. 9 indexed citations
10.
Laws, Mark, Charlotte K. Hind, Khondaker Miraz Rahman, J. Mark Sutton, & Matthew E. Wand. (2020). Whole Genome Sequencing of Staphylococcus aureus SA-1199B Reveals Previously Unreported Mutations. International Journal of Antimicrobial Agents. 57(1). 106225–106225.
11.
Laws, Mark, et al.. (2019). Antibiotic resistance breakers: current approaches and future directions. FEMS Microbiology Reviews. 43(5). 490–516. 230 indexed citations
12.
Jeeves, Rose E., Christopher Moon, Shirin Jamshidi, et al.. (2019). Noncytotoxic Pyrrolobenzodiazepine–Ciprofloxacin Conjugate with Activity against Mycobacterium tuberculosis. ACS Omega. 4(25). 20873–20881. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philipp Uhl Breakdown of academic impact, for papers by Asif Shahriar Breakdown of academic impact, for papers by Sabesan Yoganathan Breakdown of academic impact, for papers by Fenglin Yin Breakdown of academic impact, for papers by Michael Wong Breakdown of academic impact, for papers by Ibrahim M. El‐Deeb Breakdown of academic impact, for papers by K. M. Kaderi Kibria Breakdown of academic impact, for papers by Fereidoon Daryaee Breakdown of academic impact, for papers by Prabhanshu Tripathi Breakdown of academic impact, for papers by Catherine Piveteau
Rankless by CCL
2026